AI Hallucination ResearchAudiencesSectorsInternational / MultilateralPharmaceuticalsLegalDetail › Finding
Pharmaceuticals × Legal — International / Multilateral · updated 2026-05-31
Share / Print Twitter LinkedIn Email

Finding#2 — DSI benefit-sharing article citation

RLB Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004
AI's failure:Exposed Fabrication Risk for Pharmaceuticals × Legal:Wrong deliverable
What the RLB Specialist Panel found
Question (paraphrased to protect IP)

Does the BBNJ Agreement's benefit-sharing framework cover digital sequence information derived from marine organisms in international waters, and under which article?

RLB's analysis

The model attributed the digital sequence information benefit-sharing obligation to Article 15.5 when it appears in Article 14(1). The substantive conclusion — that DSI is covered by the benefit-sharing framework — is correct, but the article citation is wrong. For practitioners drafting compliance frameworks or legal opinions around the Agreement's DSI obligations, an incorrect article reference is a material error that would require correction before use.

AI Head's analysis — what weakness in the AI model caused this

This finding implicates article-level precision in the training data. The model correctly identified that DSI is covered by the benefit-sharing framework but placed the obligation in Article 15.5 rather than Article 14(1). The error is consistent with models that have learned topical summaries of the Agreement — 'DSI is covered' — without the article-level mapping that practitioners need. Structured article-map extraction for this instrument would address both this finding and the Article 8 vs 22(2) error in the Opus 4.7 findings.

Impact for Legal Teams in Pharmaceuticals Sector in international jurisdictions working with the BBNJ High Seas Biodiversity Agreement

AI tools correctly identified that the BBNJ Agreement subjects digital sequence information derived from high-seas marine genetic resources to fair and equitable benefit-sharing obligations, but cited the wrong article as the source of that rule. The DSI benefit-sharing obligation is established in Article 14(1); AI tools cited Article 15.5 instead, then self-corrected when challenged, acknowledging the citation was an approximation.

For a Legal team drafting internal compliance guidance or reviewing a partner's regulatory mapping, an incorrect article cross-reference is a credibility risk: if the firm's position is tested in regulatory correspondence or external review, counsel or counterparties checking the cited provision will find a mismatch. While the substantive outcome (DSI is covered) is correct, the mis-citation may cause the firm to misread the provision's precise scope and conditions, and undermines confidence in the broader legal work product resting on it.

References — raw findings (per AI model)
This finding also affects
← Previous finding Finding#1 — Retroactivity of MGR benefit-sharing obligations
Cite this finding

Each finding has a stable Citation ID (RLB-F-… for aggregated case-study findings, RLB-H-… for raw per-model hallucinations) — like a DOI, the ID always resolves to the canonical finding even if URLs change.

RLB Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004
Plain text Download
RegLeg Specialist Panel (2026). "Finding#2 — DSI benefit-sharing article citation — Pharmaceuticals × Legal — International / Multilateral." Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004. RegLegBrief AI Hallucination Research, published 2026-05-31. https://reglegbrief.com/regulators/j1/int/untc/bbnj-high-seas-biodiversity-agreement-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/
APA 7th edition Download
RegLeg Specialist Panel. (2026). Finding#2 — DSI benefit-sharing article citation [Hallucination finding RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004]. RegLegBrief AI Hallucination Research. https://reglegbrief.com/regulators/j1/int/untc/bbnj-high-seas-biodiversity-agreement-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/
Bluebook / OSCOLA (US + UK legal) Download
RegLeg Specialist Panel, Finding#2 — DSI benefit-sharing article citation [RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004], RegLegBrief AI Hallucination Research (May 31, 2026), https://reglegbrief.com/regulators/j1/int/untc/bbnj-high-seas-biodiversity-agreement-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/.
BibTeX Download
@misc{reglegbrief_RLB_F_INT_UNTC_BBNJ_HIGH_SEAS_BIODIVERSITY_AGREEMENT_2023_Q004,
  author    = {RegLeg Specialist Panel},
  title     = {Finding#2 — DSI benefit-sharing article citation},
  year      = {2026},
  publisher = {RegLegBrief AI Hallucination Research},
  note      = {Hallucination finding Citation ID: RLB-F-INT-UNTC-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-Q004},
  url       = {https://reglegbrief.com/regulators/j1/int/untc/bbnj-high-seas-biodiversity-agreement-2023/sectors/pharmaceuticals/legal/finding/INT-UNTC-INT-001-BBNJ-HIGH-SEAS-BIODIVERSITY-AGREEMENT-2023-v1-004/}
}
← Back to case study summary Case study detail →